You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nivolumab (OPDIVO®)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Gastric Cancer Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), Nivolumab

Recruiting
  • Metastatic Gastric Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • Nivolumab Injection
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Aug 23, 2023

Bladder Cancer Trial in United States (Nivolumab, Nivolumab/Lirilumab)

Completed
Has Results
  • Bladder Cancer
  • Tampa, Florida
  • +7 more
Nov 4, 2022

Advanced Renal Cell Carcinoma Trial (Botensilimab, Balstilimab, Ipilimumab)

Not yet recruiting
  • Advanced Renal Cell Carcinoma
  • (no location specified)
Jun 23, 2023

Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

Not yet recruiting
  • Metastatic Melanoma
  • Skin Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Mar 9, 2023

HIV I Infection Trial in Melbourne (Nivolumab 10 MG/ML [Opdivo], Saline)

Not yet recruiting
  • HIV I Infection
  • Nivolumab 10 MG/ML [Opdivo]
  • Saline
  • Melbourne, Victoria, Australia
    Alfred Hospital - Department of Infecious Diseases
May 16, 2022

Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)

Not yet recruiting
  • Castration-resistant Prostate Cancer
  • Metastatic Cancer
  • (no location specified)
Aug 12, 2022

Leukoplakia, Oral Trial in Boston (Nivolumab)

Active, not recruiting
  • Leukoplakia, Oral
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 19, 2022

Metastatic Breast Cancer, Brain Metastases Trial in Tampa (Nivolumab, Stereotactic Radiosurgery)

Active, not recruiting
  • Metastatic Breast Cancer
  • Brain Metastases
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 17, 2022

Melanoma Trial in Tampa (CC-122, Nivolumab)

Completed
Has Results
  • Melanoma
  • Tampa, Florida
    H Lee Moffitt Cancer Center and Research Institute
Sep 27, 2022

Non-Clear Cell Renal Cell Carcinoma Trial in Duarte (XL092, Nivolumab, Sunitinib Malate)

Recruiting
  • Non-Clear Cell Renal Cell Carcinoma
  • Duarte, California
    Exelixis Clinical Site #1
Jan 13, 2023

Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

Recruiting
  • Glioblastoma
  • +3 more
  • Nivolumab-Placebo
  • +4 more
  • Los Angeles, California
  • +3 more
Jan 16, 2023

Metastatic Melanoma, Metastasis to Brain Trial in Tampa, Houston (Nivolumab, Ipilimumab, Nivolumab + Relatlimab)

Recruiting
  • Metastatic Melanoma
  • Metastasis to Brain
  • Tampa, Florida
  • +1 more
Jan 30, 2023

Ovarian Cancer Trial in Houston (Nivolumab, Etigilimab)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Head Neck Cancer Trial in Houston (Nivolumab)

Recruiting
  • Head and Neck Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Sep 13, 2022

Mucinous Tumor, Colorectal Tumor, Appendiceal Tumor Trial in Philadelphia (Nivolumab, Ipilimumab)

Terminated
Has Results
  • Mucinous Adenocarcinoma of the Colon
  • Mucinous Adenocarcinoma of the Rectum
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Sep 26, 2022

Merkel Cell Carcinoma, Skin Cancer Trial in Tampa, Columbus (Nivolumab, Ipilimumab, Stereotactic Body Radiation Therapy (SBRT))

Active, not recruiting
  • Merkel Cell Carcinoma
  • Skin Cancer
  • Tampa, Florida
  • +1 more
Nov 11, 2022

Effect of Drug Trial in Taichung (Nivolumab, all trans retinoic acid)

Completed
  • Effect of Drug
  • Taichung, Please Select, Taiwan
    China Medical University Hospital
Jul 28, 2022

Oropharynx Squamous Cell Carcinoma Trial in Ann Arbor (Nivolumab, Carboplatin, Paclitaxel)

Active, not recruiting
  • Oropharynx Squamous Cell Carcinoma
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 20, 2022

CNS B-Cell Non-Hodgkin Lymphoma, Recurrent CNS Lymphoma, Refractory CNS Lymphoma Trial in Houston (Ibrutinib, Nivolumab)

Recruiting
  • Central Nervous System B-Cell Non-Hodgkin Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV Trial in Australia (BMS-986369,

Not yet recruiting
  • Follicular Lymphoma Stage II
  • +2 more
  • Ballarat, Victoria, Australia
  • +4 more
Mar 15, 2023

Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant

Recruiting
  • Atypical Teratoid Rhabdoid Tumor
  • +6 more
  • Boston, Massachusetts
  • +1 more
Jan 23, 2023

Leptomeningeal Disease Trial in Germany (Nivolumab [Opdivo])

Recruiting
  • Leptomeningeal Disease
  • Nivolumab [Opdivo]
  • Freiburg, Germany
  • +6 more
Nov 2, 2022

Melanoma Trial in Washington, Baltimore, Hackensack (Nivolumab, Ipilimumab, Cabozantinib)

Suspended
  • Melanoma
  • Washington, District of Columbia
  • +2 more
Jan 18, 2023

Metastatic Uveal Melanoma Trial in Miami (Nivolumab, Relatlimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Miami, Florida
    University of Miami Sylvester Comprehensive Cancer Center
Aug 23, 2022

Hodgkin Lymphoma Trial in Moscow (Nivolumab)

Recruiting
  • Hodgkin Lymphoma
  • Moscow, Russian Federation
    The Federal Budget-Funded Institution National Medical Surgical
Oct 31, 2022